Recombinant Gromphadorhina grandidieri Sulfakinin-1

What is Sulfakinin-1 and what are its primary functions in Gromphadorhina grandidieri?

Sulfakinin-1 (SK-1) is a sulfated neuropeptide found in the Madagascar hissing cockroach Gromphadorhina grandidieri that belongs to the broader family of arthropod sulfakinins. Like other insect sulfakinins, it primarily functions as a satiety factor and digestive regulator. Sulfakinins display structural and functional similarities with vertebrate peptides gastrin and cholecystokinin, suggesting evolutionary conservation of these signaling pathways . In cockroaches, SK-1 likely plays significant roles in regulating food intake, digestive enzyme secretion, and gut motility. Research in other insect species has demonstrated that sulfakinins reduce food uptake and have pronounced effects on digestive enzyme secretion from both the midgut and gastric caeca . The characteristic sulfation of the tyrosine residue is crucial for biological activity, particularly in digestive enzyme regulation .

How do the sequence and structure of G. grandidieri Sulfakinin-1 compare to other arthropod sulfakinins?

While the exact sequence of G. grandidieri Sulfakinin-1 is not directly reported in the provided search results, sulfakinins from various cockroach species typically share high sequence homology, especially in the C-terminal region containing the sulfated tyrosine residue. Based on patterns observed in other blattodeans (cockroaches), G. grandidieri SK-1 likely has a structure consisting of 8-12 amino acids with a conserved C-terminal motif including the sulfated tyrosine, similar to those found in other Blaberidae family members . The sequence conservation parallels what has been observed with CAPA peptides in cockroaches, where peptide sequences have been useful for phylogenetic analysis . Sequence alignment with sulfakinins from related species would help place G. grandidieri SK-1 in an evolutionary context within the broader arthropod sulfakinin family.

What expression systems have been most successful for recombinant production of insect neuropeptides?

For recombinant production of insect neuropeptides like sulfakinins, Chinese Hamster Ovary (CHO) cell lines, particularly CHO DG44 cells, have proven highly effective. These cells have been successfully used to produce other insect peptide hormones, as demonstrated in the recombinant production of eel follicle-stimulating hormone (FSH) with high yields reaching 4000-5000 ng/mL after 9 days of cultivation . For successful expression of functional sulfakinins, the expression system must support post-translational modifications, particularly tyrosine sulfation, which is crucial for biological activity . E. coli systems are less suitable for sulfakinin production due to their inability to perform this critical modification. When establishing stable transfected cell lines, it's important to select and isolate single cells expressing the target protein through limiting dilution or fluorescence-activated cell sorting (FACS) to obtain homogeneous high-producing clones .

What strategies can improve the yield and stability of recombinant G. grandidieri Sulfakinin-1?

Several strategies can enhance the yield and stability of recombinant G. grandidieri Sulfakinin-1 production:

• Optimized expression constructs: Designing constructs with strong promoters (such as CMV) and incorporating signal peptides to facilitate secretion can significantly improve yields, as demonstrated in recombinant hormone production .

• Fusion protein approaches: Creating fusion proteins with stabilizing partners (e.g., thioredoxin or GST) or using linker sequences can improve folding and stability. Research on eel FSH showed that inserting a linker including the equine chorionic gonadotropin β-subunit carboxyl-terminal peptide region between subunits improved biological activity .

• Cell line optimization: Selecting high-producing CHO DG44 clones and optimizing culture conditions can achieve yields of 4000-5000 ng/mL, similar to what was achieved with recombinant eel FSH .

• Post-translational modifications: Ensuring proper sulfation of the critical tyrosine residue is essential, as this modification is crucial for biological activity, particularly for effects on digestive enzyme secretion .

• Stabilized analogs: Developing peptidomimetic analogs with enhanced stability while maintaining biological activity, similar to approaches used for locust sulfakinin .

What are the most effective methods for purification and quality control of recombinant sulfakinins?

Effective purification and quality control methods for recombinant sulfakinins include:

Purification strategies:

• Affinity chromatography: Using antibodies against sulfakinins or adding affinity tags (His, FLAG) to facilitate purification.

• Ion-exchange chromatography: Separating based on charge differences, which is particularly useful for sulfated versus non-sulfated variants.

• Reverse-phase HPLC: For high-resolution purification based on hydrophobicity differences.

Quality control methods:

• Mass spectrometry (MS): Essential for confirming molecular weight and sulfation status. The molecular weight of sulfated peptides will differ from non-sulfated variants by +80 Da (sulfate group).

• SDS-PAGE and Western blotting: For assessing purity and immunoreactivity, with expected molecular weights similar to those observed for other small neuropeptides (typically appearing as bands between 8-40 kDa depending on glycosylation) .

• Enzymatic deglycosylation: Treatment with PNGase F can remove N-glycosylation and reveal the core peptide size, similar to approaches used for recombinant hormones .

• Bioactivity assays: Functional testing using gut motility, enzyme secretion, or food intake assays to confirm biological activity, as the sulfation status critically affects functionality .

How can recombinant G. grandidieri Sulfakinin-1 be structurally characterized and its post-translational modifications confirmed?

Structural characterization of recombinant G. grandidieri Sulfakinin-1 requires comprehensive analysis of both primary sequence and post-translational modifications:

• Tandem mass spectrometry (MS/MS): This is the gold standard method for neuropeptide sequencing, allowing direct sequence determination from single specimens. Similar approaches have been successful for characterizing CAPA peptides from cockroaches .

• Post-translational modification analysis:

  • Tyrosine sulfation: Neutral loss of the sulfate group (-80 Da) during mass spectrometry is characteristic and can be monitored using precursor ion scanning.

  • Glycosylation analysis: Treatment with deglycosylation enzymes (PNGase F for N-glycans) followed by MS analysis can reveal glycosylation patterns .

• Circular dichroism (CD) spectroscopy: To analyze secondary structure elements and conformational changes upon receptor binding.

• NMR spectroscopy: For detailed three-dimensional structure determination, though this requires larger amounts of purified peptide.

• Site-directed mutagenesis: Creating variants with altered post-translational modification sites can confirm the importance of specific modifications for biological activity, as demonstrated for the critical sulfated tyrosine in sulfakinins .

What assays can effectively measure the biological activity of recombinant G. grandidieri Sulfakinin-1?

Several complementary assays can effectively measure biological activity of recombinant G. grandidieri Sulfakinin-1:

• Food intake assays: Quantitative measurement of food consumption following sulfakinin administration. Studies in locusts demonstrated that sulfakinin reduces food uptake, establishing a clear biological readout .

• Digestive enzyme secretion assays: Measurement of enzyme release from midgut and gastric caeca following sulfakinin treatment. This provides a sensitive readout as sulfakinins effectively reduce digestive enzyme secretion from both tissues .

• Gut contraction measurements: Ex vivo monitoring of gut motility in isolated gut preparations using video-microscopy or force transducers.

• Proteolytic activity measurements: Assessing changes in proteolytic enzyme activity in gut contents following sulfakinin administration. In locusts, sulfakinin injection elicited reduction in proteolytic activity of gastric caeca contents .

• Signal transduction assays: Measuring activation of second messenger pathways (cAMP, Ca²⁺, pERK1/2) in receptor-expressing cells. Similar approaches have been used for other peptide hormones, showing sharp peaks in pERK1/2 activation at 5 minutes followed by rapid decline .

• Receptor binding assays: Using labeled sulfakinin to measure binding affinity to its receptor, comparing sulfated and non-sulfated forms.

How do the effects of recombinant and native G. grandidieri Sulfakinin-1 compare in physiological assays?

When comparing recombinant and native G. grandidieri Sulfakinin-1, researchers should consider several factors:

• Post-translational modifications: The sulfation status of the tyrosine residue is critical for biological activity. Recombinant sulfakinins produced in systems that cannot properly sulfate tyrosine may show significantly reduced potency compared to native peptides .

• Dose-response relationships: EC₅₀ values should be determined for both native and recombinant peptides across multiple assays. Minor differences in structure might yield slight variations in potency, as seen with recombinant eel FSH mutants showing 1.23-fold changes in EC₅₀ values compared to wild-type .

• Temporal dynamics: The duration of action may differ between native and recombinant peptides. For instance, in signal transduction studies of other peptide hormones, pERK1/2 activation typically shows a sharp peak at 5 minutes followed by rapid decline .

• Tissue specificity: Both peptides should be tested across multiple tissues to ensure the recombinant version maintains the appropriate tissue tropism of the native peptide.

• Comparative table: Researchers should document comparisons using a standardized table format:

What is known about Sulfakinin-1 receptors in G. grandidieri and how can recombinant SK-1 be used to characterize them?

While specific information about G. grandidieri Sulfakinin-1 receptors is not directly provided in the search results, sulfakinin receptors (SKRs) in insects are typically G protein-coupled receptors (GPCRs) that show homology to cholecystokinin receptors in vertebrates . To characterize these receptors:

• Receptor identification: Using bioinformatic approaches to identify putative SKR sequences in G. grandidieri transcriptome/genome data, based on homology to known insect SKRs. Similar approaches have been successful in identifying neuropeptide receptors in other insects .

• Receptor expression: Heterologous expression of candidate SKRs in cell lines (HEK293, CHO) for functional characterization.

• Binding studies: Using labeled recombinant SK-1 to:

  • Determine binding affinity (Kd) and capacity (Bmax)

  • Map receptor distribution in tissues

  • Compare sulfated vs. non-sulfated peptide binding

• Signaling pathway analysis: Characterizing downstream signaling pathways activated by receptor binding using:

  • Calcium mobilization assays

  • cAMP accumulation measurements

  • ERK1/2 phosphorylation studies, which typically show sharp activation peaks at 5 minutes

• Structure-activity relationship studies: Using modified recombinant SK-1 variants to:

  • Identify critical residues for receptor binding and activation

  • Develop receptor subtype-selective analogs

  • Design antagonists for experimental blockade of SK signaling

What are the most common challenges in expressing functional recombinant G. grandidieri Sulfakinin-1?

Common challenges in expressing functional recombinant G. grandidieri Sulfakinin-1 include:

• Post-translational modifications: Ensuring proper tyrosine sulfation is the most critical challenge, as this modification is essential for biological activity. Many expression systems lack the necessary tyrosylprotein sulfotransferases or have insufficient sulfation capacity .

• Low expression yields: Small peptides can be rapidly degraded or poorly expressed. Strategies to overcome this include:

  • Using fusion protein approaches

  • Optimizing codon usage for the expression system

  • Selecting high-producing clones, as has been done for recombinant hormone production where yields reached 4000-5000 ng/mL

• Peptide solubility and aggregation: Small, hydrophobic peptides may aggregate during expression or purification.

• Proteolytic degradation: Host cell proteases may degrade the recombinant peptide. Protease inhibitor cocktails and protease-deficient host strains can mitigate this.

• Proper folding: Although sulfakinins are relatively small peptides, ensuring the correct conformation is essential for receptor recognition and biological activity.

• Batch-to-batch variation: Inconsistent post-translational modifications between production batches can lead to variable activity.

How can researchers distinguish between effects of sulfated and non-sulfated forms of recombinant Sulfakinin-1?

To distinguish between effects of sulfated and non-sulfated forms of recombinant Sulfakinin-1:

• Parallel production: Express both sulfated and non-sulfated variants (the latter by mutating the tyrosine residue or using expression systems lacking sulfation capability).

• Analytical confirmation: Confirm sulfation status using:

  • Mass spectrometry (80 Da mass difference)

  • Antibodies specific to sulfated epitopes

  • Special staining techniques for sulfated proteins

• Comparative bioassays: Test both variants in parallel across multiple assays:

  • Digestive enzyme secretion: Studies in locusts showed the sulfated tyrosine is crucial for effects on digestive enzyme secretion

  • Food intake assays: Compare dose-response curves for both variants

  • Receptor binding studies: Determine affinity differences

• Data presentation: Results should be presented as comparative dose-response curves with calculated EC₅₀ values for both variants:

• Controls: Include enzymatic desulfation experiments, where treating the sulfated peptide with arylsulfatases should convert it to a form with activity matching the non-sulfated variant.

What strategies can address inconsistent results in SK-1 bioactivity assays?

To address inconsistency in sulfakinin bioactivity assays:

• Standardization of peptide quantification:

  • Use multiple quantification methods (UV absorbance, BCA, amino acid analysis)

  • Create internal standards for each assay batch

  • Express results in molar concentrations rather than weight

• Experimental controls:

  • Include positive controls (known active sulfakinins from related species)

  • Use non-sulfated variants as comparative controls

  • Implement vehicle controls to account for carrier effects

• Physiological variables:

  • Standardize test animal age, sex, nutritional state, and circadian time

  • For feeding assays, control pre-test starvation periods

  • For enzyme secretion assays, standardize tissue collection and handling

• Technical considerations:

  • Verify peptide stability under assay conditions

  • Account for potential adsorption to plasticware

  • Consider pharmacokinetic factors (timing, route of administration)

• Data analysis:

  • Use appropriate statistical methods for dose-response data

  • Apply curve-fitting algorithms to determine EC₅₀ values

  • Consider using Area Under the Curve (AUC) approaches for temporal response data

• Independent verification:

  • Test multiple peptide batches

  • Perform interlaboratory validation of key findings

How might understanding G. grandidieri Sulfakinin-1 signaling contribute to comparative endocrinology?

Understanding G. grandidieri Sulfakinin-1 signaling offers valuable insights for comparative endocrinology:

• Evolutionary conservation: Sulfakinins share structural and functional similarities with vertebrate cholecystokinin and gastrin, suggesting evolutionary conservation of these signaling systems across diverse taxa . Detailed characterization of G. grandidieri SK-1 would provide another data point for understanding how these signaling pathways evolved across arthropods and between arthropods and vertebrates.

• Phylogenetic analysis: Like CAPA peptides, sulfakinin sequences could be useful for phylogenetic analysis within cockroaches and other insects . Comparing sequences across Blaberidae family members could reveal evolutionary patterns and selective pressures on digestive regulation systems.

• Functional conservation: Comparing the effects of G. grandidieri SK-1 on feeding and digestion with those in other insects (like locusts ) and vertebrates would highlight functional conservation of satiety signaling across distant animal groups.

• Receptor-ligand co-evolution: Analyzing how sulfakinin peptides and their receptors co-evolved across species provides insights into molecular evolution of peptide-receptor pairs.

• Convergent evolution: The study of SK-1 signaling in different insect taxa may reveal cases of convergent evolution in feeding regulation mechanisms.

What potential applications exist for recombinant G. grandidieri Sulfakinin-1 in insect physiology research?

Recombinant G. grandidieri Sulfakinin-1 has numerous potential applications in insect physiology research:

• Feeding regulation studies: As a satiety factor, recombinant SK-1 can be used to manipulate feeding behavior in experimental settings to study hunger signaling pathways .

• Digestive physiology: SK-1 can serve as a tool to modulate digestive enzyme secretion, enabling studies of gut function and regulation .

• Comparative physiology: Comparing effects across different cockroach species can reveal evolutionary patterns in digestive regulation.

• Receptor characterization: Labeled recombinant SK-1 can be used to identify and characterize SK receptors, map their distribution, and study their signaling pathways.

• Development of research tools:

  • Receptor-specific antagonists

  • Modified peptides with extended half-lives

  • Fluorescently-labeled SK analogs for imaging studies

• Physiological integration: Investigating interactions between SK signaling and other regulatory systems (insulin-like peptides, juvenile hormone) to understand how multiple signals are integrated to control feeding and metabolism.

• Environmental adaptation: Studying how SK signaling changes in response to diet, temperature, or other environmental factors.

How can structural analysis of recombinant SK-1 guide the development of mimetic compounds for research?

Structural analysis of recombinant SK-1 can guide mimetic compound development through:

• Structure-activity relationship (SAR) studies: Systematic modification of amino acid residues to determine which are essential for:

  • Receptor binding

  • Receptor activation

  • Resistance to degradation

  These studies can identify minimal active fragments and non-peptide scaffolds that mimic key interaction points.

• Peptidomimetic design strategies:

  • Backbone modifications (N-methylation, β-amino acids)

  • Cyclization to restrict conformational flexibility

  • Non-hydrolyzable sulfate mimetics that resist enzymatic removal

  • D-amino acid substitutions to increase stability

• Experimental validation: Testing mimetic analogs in the digestive enzyme secretion assay has proven effective in evaluating SK mimetics, though these analogs typically show milder effects than the natural peptides .

• Comparative efficacy table:

• Receptor modeling: Using computational approaches to model the SK receptor binding pocket can guide rational design of non-peptide mimetics that maintain the spatial arrangement of key interaction points.